Gmail Calendar Documents Reader Web more »
Recently Visited Groups | Help | Sign in
Google Groups Home
Progression of clinically stable lymphedema on lymphoscintigraphy.
There are currently too many topics in this group that display first. To make this topic appear first, remove this option from another topic.
There was an error processing your request. Please try again.
flag
  1 message - Collapse all  -  Translate all to Translated (View all originals)
The group you are posting to is a Usenet group. Messages posted to this group will make your email address visible to anyone on the Internet.
Your reply message has not been sent.
Your post was successful
 
From:
To:
Cc:
Followup To:
Add Cc | Add Followup-to | Edit Subject
Subject:
Validation:
For verification purposes please type the characters you see in the picture below or the numbers you hear by clicking the accessibility icon. Listen and type the numbers you hear
 
lymphedemapeople  
View profile  
 More options Sep 22, 12:28 am
From: lymphedemapeople <lymphedemapeo...@gmail.com>
Date: Mon, 21 Sep 2009 21:28:14 -0700 (PDT)
Local: Tues, Sep 22 2009 12:28 am
Subject: Progression of clinically stable lymphedema on lymphoscintigraphy.
Progression of clinically stable lymphedema on lymphoscintigraphy.

Clin Nucl Med. 2009 Sep

Luongo JA, Scalcione LR, Katz DS, Yung EY.
Department of Radiology, Winthrop-University Hospital, Mineola, NY
11501, USA.

Lymphedema is due to dysfunction in lymphatic transport, and is
divided into primary and secondary subtypes. Primary lymphedema is a
congenital lymphatic abnormality or dysfunction whereas secondary
lymphedema is characterized by pathologic disruption or obstruction of
a previously-normal lymphatic system. The stage of lymphedema is
determined clinically. Lymphoscintigraphy, however, may be used to
assess disease extent, for early detection of disease progression, and
can be used to direct therapy. We report a case of a 56-year-old woman
with clinically stable lymphedema of 5 years, yet with
lymphoscintigraphy findings compatible with disease progression.

http://www.ncbi.nlm.nih.gov/pubmed/19692818?ordinalpos=26&itool=Entre...


    Reply to author    Forward  
You must Sign in before you can post messages.
To post a message you must first join this group.
Please update your nickname on the subscription settings page before posting.
You do not have the permission required to post.
End of messages
« Back to Discussions « Newer topic     Older topic »

Create a group - Google Groups - Google Home - Terms of Service - Privacy Policy
©2009 Google